U.S. stock benchmarks on Tuesday were poised to extend gains in the second trading day in February with investors encouraged by news on the pace of vaccines in the U.S., the prospect of more fiscal aid from Congress, and a decline in the frenzy of retail trading in heavily shorted stocks.
A slate of earnings reports are also in focus Tuesday, including Pfizer
before the bell and mega-capitalization stocks Amazon
and Google parent Alphabet
slated to report after the close.